silver has been researched along with Fascioliasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelilah, BA; El-Sadek, MS; Elhariry, HM; Gherbawy, YA; Shalaby, IM | 1 |
1 other study(ies) available for silver and Fascioliasis
| Article | Year |
|---|---|
The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole.
Topics: Benzimidazoles; Drug Combinations; Fascioliasis; Humans; Metal Nanoparticles; Nanotechnology; Particle Size; Silver; Trichoderma; Triclabendazole | 2013 |